Many are called MDS cell lines: One is chosen

Leukemia Research

Volumn 33, Issue 8, 2009, Pages 1011-1016

  Drexler, Hans G ^a   Dirks, Willy G ^a   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

AML; Cell lines; Leukemia; MDS; Myelodysplastic syndromes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CELL CYCLE PHASE; CELL LINE; CELL LINEAGE; CHROMOSOME ANALYSIS; DNA FINGERPRINTING; HUMAN; LEUKEMIA CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENOMIC INSTABILITY; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MODELS, BIOLOGICAL; MYELODYSPLASTIC SYNDROMES;

EID: 67349140937     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.005     Document Type: Review

References (45)

1. Corey S.J., Minden M.D., Barber D.L., Kantarjian H., Wang J.C.Y., and Schimmer A.D. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 7 (2007) 118-129
2. Germing U., Aul C., Niemeyer C.M., Haas R., and Bennett J.M. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 87 (2008) 691-699
3. Sekeres M.A. The myelodysplastic syndromes. Expert Opin Biol Ther 7 (2007) 369-377
4. Jädersten M., and Hellström-Lindberg E. Myelodysplastic syndromes: biology and treatment. J Intern Med 265 (2009) 307-328
5. MacLeod R.A.F., Nagel S., Scherr M., Schneider B., Dirks W.G., Uphoff C.C., et al. Human leukemia and lymphoma cell lines as models and resources. Curr Med Chem 15 (2008) 339-359
6. Andersson A., Edén P., Lindgren D., Nilsson J., Lassen C., Heldrup J., et al. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia 19 (2005) 1042-1050
7. Rücker F.G., Sander S., Döhner K., Döhner H., Pollack J.R., and Bullinger L. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia 20 (2006) 994-1001
8. Drexler HG. Guide to Leukemia-Lymphoma Cell Lines. Braunschweig; 2005 [eBook on CD].
9. Drexler H.G. Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes. Leuk Res 24 (2000) 109-115
10. MacLeod R.A.F., Dirks W.G., Matsuo Y., Kaufmann M., Milch H., and Drexler H.G. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83 (1999) 555-563
11. Boehrer S., Ades L., Braun T., Galluzi L., Grosjean J., Fabre C., et al. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 111 (2008) 2170-2180
12. Dirks W.G., and Drexler H.G. Authentication of cancer cell lines by DNA fingerprinting. In: Langdon S.P. (Ed). Cancer Cell Culture - methods and protocols (2004), Humana Press, Totowa, NJ 43
13. Banerjee R., Bekesi J.G., Tarcsafalvi A., Sperber K., Deak G., Choi H.S.H., et al. Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proc Natl Acad Sci USA 89 (1992) 9996-10000
14. Steube K., Gignac S.M., Hu Z.B., Teepe D., Harms D., Kabisch H., et al. In vitro culture studies of childhood myelodysplastic syndrome: establishment of cell line MUTZ-1. Leuk Lymphoma 25 (1997) 345-363
15. Nagai M., Seki S., Kitahara T., Abe T., Minato K., Watanabe S., et al. A novel human myelomonocytoid cell line, P39/Tsugane, derived from overt leukemia following myelodysplastic syndrome. Gann 75 (1984) 1100-1107
16. Bogdanovic G., Jurisic V., Kraguljac N., Mrdjanovic J., Jakimov D., Krtolica K., et al. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome. Leuk Res 31 (2007) 1097-1105
17. Bergamaschi G., Carlo Stella C., Cattoretti G., Invernizzi R., Maserati E., Nalli G., et al. Establishment and characterization of a B-cell line derived from a patient with myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. Br J Haematol 78 (1991) 167-172
18. McCarty T.M., Rajamaran S., Elder F.F.B., Gadson P., and Thompson E.B. Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome. Blood 70 (1987) 1665-1672
19. Yamaguchi Y., Nishio H., Kasahara T., Ackerman S.J., Koyanagi J., and Suda T. Models of lineage switching in hematopoietic development: a new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential. Leukemia 12 (1998) 1430-1439
20. Boultwood J., Fidler C., Strickson A.J., Watkins F., Gama S., Kearney L., et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood (2002) 4638-4641
21. MacLeod R.A.F., Kaufmann M., and Drexler H.G. Cytogenetic harvesting of commonly used tumor cell lines. Nat Protoc 2 (2007) 372-382
22. Giavazzi R., Di Berardino C., Garofalo A., Motta T., Gobbi A., Scanziani E., et al. Establishment of human acute myelogenous leukemia lines secreting interleukin-1ß in SCID mice. Int J Cancer 61 (1995) 280-285
23. Munker R, Lowery Nordberg M, Veillon D, Williams BJ, Roggero A, Kern W, et al. Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH). Leuk Res, in press.
24. Imagama S., Abe A., Suzuki M., Hayakawa F., Katsumi A., Emi N., et al. LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22). Eur J Haematol 79 (2007) 25-31
25. Chiba S., Takaku F., Tange T., Shibuya K., Misawa C., Sasaki K., et al. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 78 (1991) 2261-2268
26. Hamaguchi H., Suzukawa K., Nagata K., Yamamoto K., Yagasaki F., and Morishita K. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, p210 and p190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Br J Haematol 98 (1997) 399-407
27. Matsuda M., Maeda Y., Sumimoto Y., Nawata H., Sano T., Higashishiba M., et al. Establishment of a myelodysplastic syndrome (MDS)/secondary AML-derived T lymphoid cell line K2-MDS. Leuk Res 24 (2000) 103-108
28. Toki T., Kanezaki R., Adachi S., Fujino H., Xu G., Sato T., et al. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. Leukemia 23 (2009) 95-103
29. Nishimaki J., Miyazawa K., Yaguchi M., Katagiri T., Kawanishi Y., Toyama K., et al. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation. Leukemia 13 (1999) 1399-1405
30. Matsuo Y., MacLeod R.A.F., Uphoff C.C., Drexler H.G., Nishizaki C., Katayama Y., et al. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia 11 (1997) 1469-1477
31. Matsuo Y., Drexler H.G., Harashima A., Okochi A., Kojima K., Asakura S., et al. Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes. Leuk Res 29 (2005) 701-710
32. Mizobuchi N., Takahashi I., Horimi T., Yamamoto M., Hamada K., Yorimitsu S., et al. Establishment of a new myeloid cell line with i(17q) as the sole chromosomal anomaly from the bone marrow of a patient with myelodysplastic syndrome. Acta Med Okayama 51 (1997) 227-232
33. Hu Z.B., MacLeod R.A.F., Meyer C., Quentmeier H., and Drexler H.G. New acute myeloid leukemia-derived leukemia cell line: MUTZ-8 with 5q-. Leukemia 16 (2002) 1556-1561
34. Hu Z.B., Quentmeier H., Meyer C., Kaufmann M., MacLeod R.A.F., and Drexler H.G. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17). Leuk Res 28 (2004) 509-515
35. Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., and Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia cell lines: characterization and interpretations. Blood 72 (1988) 1029-1038
36. Tohda S., Yang G.S., Ashman L.K., McCulloch E.A., and Minden M.D. Relationship between c-KIT expression and proliferation in acute myeloblastic leukemia cell lines. J Cell Physiol 154 (1993) 410-418
37. Nagai M., Fujita M., Ikeda T., Ohmori M., Kuwabara H., Yamaoka G., et al. Alterations of p53 and Rb genes in a novel human GM-CSF-dependent myeloid cell line (OHN-GM) established from therapy-related leukaemia. Br J Haematol 98 (1997) 392-398
38. Hamaguchi H., Inokuchi K., Nara N., Nagata K., Yamamoto K., Yagasaki F., et al. Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome. Int J Hematol 67 (1998) 153-164
39. Meyer S., Fergusson W.D., Oostra A.B., Medhurst A.L., Waisfisz Q., De Winter J.P., et al. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallellic FANCD1/BRCA2 mutations. Genes Chromosomes Cancer 42 (2005) 404-415
40. Matsuoka H., Murayama T., Koizumi T., Nishimura R., Kawaguchi R., and Nakagawa T. Establishment of a human myeloid cell line with trisomy 8 derived from overt leukemia following myelodysplastic syndrome. Haematologica 90 (2005) 981-982
41. Kawaguchi R., Hosokawa Y., Komine A., Tsutsumi M., Hikiji K., Ishida-Okawara A., et al. The monocytic cell line SKM-1 expresses the myeloperoxidase gene. Leukemia 6 (1992) 1296-1301
42. Downie P.A., Vogelzang N.J., Moldwin R.L., LeBeau M.M., Anastasi J., Allen R.J., et al. Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia. Cancer Res 54 (1994) 4999-5004
43. Minegishi N., Minegishi M., Tsuchiya S., Fujie H., Nagai T., Hayashi N., et al. Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. J Biol Chem 269 (1994) 27700-27704
44. Tohyama K., Tsutani H., Ueda T., Nakamura T., and Yoshida Y. Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br J Haematol 87 (1994) 235-242
45. Mishima Y., Terui Y., Mishima Y., Katsuyama M., Mori M., Tomizuka H., et al. New human myelodysplastic cell line, TER-3: G-CSF specific downregulation of Ca2+/calmodulin-dependent protein kinase IV. J Cell Physiol 191 (2002) 183-190